Application | Comment | Organism |
---|---|---|
drug development | the enzyme is a target for drugs in therapy of HCV infection | Hepacivirus C |
Protein Variants | Comment | Organism |
---|---|---|
E440G | naturally occuring mutation, location in the protein and role in RNA binding, overview | Hepacivirus C |
I11V | naturally occuring mutation, location in the protein and role in RNA binding, overview | Hepacivirus C |
I11V/I454V | naturally occuring mutation, location in the protein and role in RNA binding, overview | Hepacivirus C |
I432V | naturally occuring mutation, location in the protein and role in RNA binding, overview | Hepacivirus C |
I454V | naturally occuring mutation, location in the protein and role in RNA binding, overview | Hepacivirus C |
additional information | mutant NS5B DELTA21, produced by cells expressing the HCV replicon, shows increased ability to bind to RNA, with 8fold higher affinity compared to the wild-type, in the presence of cyclosporine A, overview. CsA-resistance mutations locate to two functionally related regions in NS5B structure. Purified recombinant NS5B mutants show higher de novo initiated RNA synthesis than the wild-type control | Hepacivirus C |
P538T | naturally occuring mutation, location in the protein and role in RNA binding, overview | Hepacivirus C |
P540A | naturally occuring mutation, lethal effect of P540A mutation | Hepacivirus C |
Q438R | naturally occuring mutation, location in the protein and role in RNA binding, overview | Hepacivirus C |
Q438R/E440G | naturally occuring mutation, location in the protein and role in RNA binding, overview | Hepacivirus C |
R556V | naturally occuring mutation, location in the protein and role in RNA binding, overview | Hepacivirus C |
S556G | naturally occuring mutation, location in the protein and role in RNA binding, overview | Hepacivirus C |
V405L | naturally occuring mutation, location in the protein and role in RNA binding, overview | Hepacivirus C |
W550R | naturally occuring mutation, location in the protein and role in RNA binding, overview | Hepacivirus C |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
cyclosporine A | inhibits HCV replication | Hepacivirus C |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Hepacivirus C | P26663 | - |
- |
Synonyms | Comment | Organism |
---|---|---|
hepatitis C virus polymerase | - |
Hepacivirus C |
NS5B | - |
Hepacivirus C |
RDRP | - |
Hepacivirus C |
RNA-dependent RNA polymerase | - |
Hepacivirus C |
General Information | Comment | Organism |
---|---|---|
malfunction | mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A, an inhibitor that is used as therpeutic against HCV-induced acute and chronic liver disease | Hepacivirus C |